Cardiol Therapeutics Inc - Ordinary Shares - Class A Stock
Cardiol Therapeutics Inc - Ordinary Shares - Class A Stock price
Key metrics
| Market capitalization | $127.18m |
| Enterprise Value | $115.54m |
| P/E (TTM) P/E ratio | negative |
| P/B ratio (TTM) P/B ratio | 16.55 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-28.15m |
| Cash position | $17.55m |
| EPS (TTM) EPS | $-0.39 |
| P/E forward | negative |
Is Cardiol Therapeutics Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Cardiol Therapeutics Inc - Ordinary Shares - Class A Stock Analysis
Analyst Opinions
5 Analysts have issued a Cardiol Therapeutics Inc - Ordinary Shares - Class A forecast:
Analyst Opinions
5 Analysts have issued a Cardiol Therapeutics Inc - Ordinary Shares - Class A forecast:
Financial data from Cardiol Therapeutics Inc - Ordinary Shares - Class A
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.29 -0.29 |
61%
61%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -28 -28 |
23%
23%
|
| Net Profit | -27 -27 |
28%
28%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Cardiol Therapeutics Inc - Ordinary Shares - Class A directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Cardiol Therapeutics Inc - Ordinary Shares - Class A Stock News
Company Profile
Cardiol Therapeutics Inc. is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.
| Head office | Canada |
| CEO | David Elsley |
| Founded | 2017 |
| Website | www.cardiolrx.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
